EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Oral Sodium to Preserve Renal Efficiency in Acute Heart Failure: A Randomized, Placebo-Controlled, Double-Blind Study

Robert A Montgomery, Joseph Mauch, Parvathy Sankar, Trejeeve Martyn, Tim Engelman, Pieter Martens, Kathleen Faulkenberg, Venu Menon, Jerry D Estep, W H Wilson Tang

Journal of Cardiac Failure · 2023

DOI: 10.1016/j.cardfail.2023.03.018 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cardiac Failure, 2023. Verfasst von Robert A Montgomery und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH. Hauptthemen laut MEDLINE: Heart Failure. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Cleveland Clinic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Evidence for modulating the sodium chloride (NaCl) intake of patients hospitalized with acute heart failure (AHF) is inconclusive. Salt restriction may not benefit; hypertonic saline may aid diuresis. OBJECTIVE: To compare the safety and efficacy of oral NaCl during intravenous (IV) diuretic therapy in renal function and weight. METHODS: Seventy hospitalized patients with AHF who were being treated with IV furosemide infusion consented to receive, randomly, 2 grams of oral NaCl or placebo 3 times a day in a double-blind manner during diuresis. Treatment efficacy (bivariate primary endpoints of change in serum creatinine levels and change in weight) was measured at 96 hours, and adverse safety events were tracked for 90 days. RESULTS: Sixty-five patients (34 NaCl, 31 placebo) were included for analysis after 5 withdrew. A median of 13 grams of NaCl was given compared to placebo. At 96 hours, there was no significant difference between treatment groups with respect to the primary endpoint (P = 0.33); however, the trial was underpowered, and there was greater than expected standard deviation in weight change. The mean change in creatinine levels and weight was 0.15 ± 0.44 mg/dL and 4.6 ± 4.2 kg in the placebo group compared with 0.04 ± 0.40 mg/dL and 4.0 ± 4.3 kg in the NaCl group (P = 0.30 and 0.57, respectively). Across efficacy and safety endpoints, we observed no significant difference between the 2 groups other than changes in serum sodium levels (-2.6 ± 2.7 in the placebo group and -0.3 ± 3.3 mEq/L in the NaCl group; P < 0.001) and in serum blood urea nitrogen levels (11 ± 15 in the placebo group; 3.1 ± 13 mEq/L in the NaCl group; P = 0.025). CONCLUSIONS: In this single-center study, liberal vs restrictive oral sodium chloride intake strategies did not impact the safety and efficacy of intravenous diuretic therapy in patients with AHF. (ClinicalTrials.gov registration NCT04334668.).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureHumansSodium ChlorideDouble-Blind MethodFurosemideDiureticsTreatment OutcomeSodiumKidney

Stichwörter der Autor:innen

Acute heart failurecongestiondietary sodiumloop diureticsnatriuresis

Substanzen

Sodium ChlorideFurosemideDiureticsSodium

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH.
  • Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH.
  • Education Institute, Cleveland Clinic, Cleveland, OH.
  • Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
  • Department of Pharmacy Practice & Science, University of Kentucky, Lexington, KY.
  • Department of Cardiology, Cleveland Clinic Weston, Weston. FL.

Förderung

  • Cleveland Clinic

Zitieren

APA

Montgomery, R. A., Mauch, J., Sankar, P., Martyn, T., Engelman, T., Martens, P., Faulkenberg, K., Menon, V., Estep, J. D., & Tang, W. H. W. (2023). Oral Sodium to Preserve Renal Efficiency in Acute Heart Failure: A Randomized, Placebo-Controlled, Double-Blind Study. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2023.03.018

Vancouver

Montgomery RA, Mauch J, Sankar P, Martyn T, Engelman T, Martens P, et al. Oral Sodium to Preserve Renal Efficiency in Acute Heart Failure: A Randomized, Placebo-Controlled, Double-Blind Study. Journal of Cardiac Failure. 2023. doi:10.1016/j.cardfail.2023.03.018

BibTeX
@article{Montgomery2023,
  author = {Montgomery, Robert A and Mauch, Joseph and Sankar, Parvathy and Martyn, Trejeeve and Engelman, Tim and Martens, Pieter and Faulkenberg, Kathleen and Menon, Venu and Estep, Jerry D and Tang, W H Wilson},
  title = {Oral Sodium to Preserve Renal Efficiency in Acute Heart Failure: A Randomized, Placebo-Controlled, Double-Blind Study},
  journal = {Journal of Cardiac Failure},
  year = {2023},
  doi = {10.1016/j.cardfail.2023.03.018}
}
Kostenlos starten →